We are live on
!
Find out more
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
32 hedge funds and large institutions have $56M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
4% more capital invested
Capital invested by funds: $53.8M → $56M (+$2.21M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 35 → 32 (-3)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $296K
Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
8
Reduced
13
Closed
6
Calls
–
Puts
$296K
Net Calls
-$296K
Net Calls Change
-$103K
Top Buyers
| 1 |
DMK
David M. Knott
|
+$225K |
| 2 |
JP Morgan Chase
New York
|
+$170K |
| 3 |
Renaissance Technologies
New York
|
+$113K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$55.7K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$46.2K |
